KEGG   DRUG: Daxibotulinumtoxin A
Entry
D10921                      Drug                                   
Name
Daxibotulinumtoxin A (USAN);
Daxibotulinumtoxin A-lanm;
Daxxify (TN)
Formula
C6708H10359N1729O1995S32
Exact mass
148080.3354
Mol weight
148171.4934
Efficacy
Antimigraine, Skeletal muscle relaxant
Comment
Treatment of galbellar lines, cervical dystonia, lateral canthal lines, migraine headaches and hyperhidrosis
Target
SNAP25 [HSA:6616] [KO:K18211]
  Pathway
hsa04721  Synaptic vesicle cycle
Brite
USP drug classification [BR:br08302]
 Dermatological Agents
  Dermatological Agents, Other
   Dermatological Agents, Miscellaneous
    Daxibotulinumtoxin A
     D10921  Daxibotulinumtoxin A (USAN)
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Nervous system
    SNAP25
     D10921  Daxibotulinumtoxin A (USAN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10921
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10921
Other DBs
CAS: 93384-43-1
PubChem: 342581778
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system